Hook & thesis
Nebius delivered a jaw-dropping Q3 with revenue of $980.8 million (up 571% year-over-year) and expanded adjusted EBITDA to roughly $465.8 million, yet the stock cratered after management raised 2026 capex and pushed back some facility deployments. I doubled down after the sell-off. Why? The core growth signal is real: contract commitments and pricing are both strong, and the company is converting that demand into revenue and substantial EBITDA in the near term. The market punished the stock for “execution risk” on a multibillion-dollar build-out and higher near-term capital needs. That’s a risk — but one that can be managed with a disciplined trade.
My actionable trade: enter long at $116.00, stop loss at $95.00, target at $210.00. I size this as a tactical, event-driven position that leans into a recovery in sentiment and better visibility on funding for capacity. Below I lay out the business, the numbers that matter, valuation context, catalysts that could drive the trade, the risks and a counterargument, and what would make me change my mind.
What Nebius does and why the market should care
Nebius is an AI-centric cloud operator that supplies large-scale GPU clusters, cloud services, and developer tools to AI builders worldwide. It bundles direct infrastructure with data and talent playbooks via specialized brands such as Toloka AI (data for generative AI), TripleTen (reskilling/edtech) and Avride (autonomous driving R&D). In short: Nebius sits at the hardware + software + services intersection that powers generative AI applications — one of the rare companies selling both capacity and adjacent services that accelerate customer deployment.
The market cares because AI workloads are massively capital-intensive and customers are hungry for hosted GPU capacity with predictable pricing and services. Nebius reported that customer prepayments and contract economics are improving — management said prepayments now exceed 100% of new capacity capex in recent deals — and the company disclosed over $12 billion in customer commitments with contract pricing north of $25 million per megawatt. That combination (large, multi-year contracts + upfront funding) changes the funding profile compared with pure-build players that carry inventory and long construction tails.
Numbers that back the thesis
- Q3 revenue: $980.8M, up 571% year-over-year; AI Cloud growth alone was called out at 643%.
- Profitability: reported earnings of $0.30 per share and adjusted EBITDA around $465.8M, suggesting much-improved operating leverage and contract economics.
- Forward scope: management targets $12-13B in 2027 revenues, and expects pretax breakeven in Q4 2027.
- Cash & capex plan: 2027 capex guidance of $40-45B with 75-85% planned funding via customer prepayments and asset-backed financing; 2026 capex was raised to $27B while 2026 revenue guidance was trimmed to $3-3.2B.
- Market reaction: the shares traded off sharply; current price is $115.81 versus a 52-week high of $299.86 and a low of $73.52. Market cap is about $31.48B.
Put together, Nebius is rapidly scaling revenue and converting better unit economics into high EBITDA margins in the quarter — but the growth story requires large, continued capital deployment and flawless execution on capacity builds or financed equivalents.
Valuation framing
At a market cap near $31.5B and Q3 trailing revenue of roughly $981M (quarter), the market is pricing in very strong forward growth already. Management’s 2027 revenue ambition of $12-13B implies roughly 1.4-1.5x expected 2027 revenue at today’s market cap, ignoring dilution and assuming no change in valuation multiple. That’s aggressive but not absurd for a company with the sort of EBITDA margins Nebius reported in Q3 (~47.5% adjusted EBITDA), provided the company can execute on capacity and financing.
Why the recent sell-off created a trade opportunity: the market punished Nebius for higher capex and deployment delays, compressing multiples and pushing the stock well below short-term averages. Technical indicators show RSI near 36, 10-day SMA at $135.91, and a negative MACD — a classic capitulation that often precedes mean-reversion if fundamentals remain intact. Short interest is meaningful but days-to-cover is low (about 2.2), which suggests short squeezes can happen but also that short sellers can be nimble.
Catalysts that support a recovery
- Liquidity/funding updates: any announcement that customer prepayments, asset-backed financings, or committed facilities cover a larger portion of the 2027 capex plan would sharply reduce perceived funding risk and could re-rate the stock.
- Capacity milestones: visible progress in bringing third-party or owned capacity online would address the execution concerns that prompted the guidance cut.
- Large customer renewals/extensions: given the $12B+ in commitments today, public disclosure of incremental multi-year deals or expanded pricing would reinforce pricing power.
- Macro stabilization in rates and credit markets: lower borrowing costs would reduce blended finance costs for Nebius’s build-out and make asset-backed financings easier and cheaper.
- Analyst sentiment stabilization: several price-target cuts hit the tape after the quarter; a handful of upgrades or restored targets on better visibility could attract flow back into the name.
Trade plan
My actionable trade is:
- Entry: $116.00
- Stop loss: $95.00
- Target: $210.00
- Direction: long
- Risk level: high
Horizon guidance: short term (10 trading days) I expect a relief bounce back toward the 10-day SMA (~$136) as volatile sentiment calms; mid term (45 trading days) I expect re-rating on funding clarity or partial capacity announcements; long term (180 trading days) the position is a play on execution toward the 2027 revenue ramp and pretax breakeven trajectory.
Why these levels? Entry at $116 reflects a post-earnings level that incorporates the market’s fear premium. The $95 stop is beneath recent selling pressure and gives room for continued volatility while protecting capital if the company’s funding picture materially deteriorates. The $210 target is achievable if the market restores even a modest portion of the valuation premium as guidance visibility improves and capacity comes online — it sits well below the 52-week high of $299.86 but represents a ~81% upside from the $116 entry, which matches the asymmetric reward profile I’m seeking given the binary catalysts ahead.
Risks and counterarguments
- Execution and capacity delays - Management already flagged delays; if third-party deployments slip further or costs run above guidance, revenue ramps could miss and capex burn could accelerate.
- Funding risk - The plan calls for tens of billions of dollars of capex in 2026-2027. If customer prepayments and asset-backed financing fall short or credit markets tighten, Nebius could face higher dilution or financing at punitive terms.
- Customer concentration and renegotiation - Large customers could renegotiate as they internalize more capacity (Microsoft, Oracle moves were cited in the tape). Loss or re-pricing of a handful of large contracts would be material.
- Macro / rates environment - Rising rates and a tougher credit backdrop make long, asset-heavy build-outs harder to finance; that could slow capacity expansion and increase financing costs.
- Valuation complacency - The market has already priced blistering growth into future years. If Nebius cannot sustain the multi-hundred percent growth trajectory, multiples could compress further.
- Counterargument: the market is right to be cautious. The business needs flawless execution on a colossal capex plan; a single meaningful slip could force an equity raise that dilutes holders and compresses upside. In that scenario, the stop at $95 protects against material downside while letting a recovery play out if the firm addresses the funding question.
What would change my view
I will materially reduce or exit this long if Nebius either announces (a) a significant equity raise at distressed levels that meaningfully dilutes/changes the risk profile, or (b) a failure to secure the asset-backed financing or customer prepayments that management says covers 75-85% of capex. Conversely, I would add to the position if Nebius publishes clear financing commitments covering the 2027 capex plan, or if there are tangible capacity-delivery dates and evidence that contract economics remain favorable.
Bottom line: this is a high-conviction, tactical long built on an asymmetric setup — exceptional current revenue growth and strong contract economics offset by real execution and funding risk. My stop is tight enough to manage those risks while giving the trade room to recover.
Key takeaways
- Nebius reported astonishing Q3 top-line and EBITDA growth but spooked investors with heavier near-term capex and deployment delays.
- That sell-off creates a tactical long opportunity at current prices if you accept execution and funding risk; my entry is $116, stop $95, target $210.
- Watch funding updates, capacity milestones, and any large customer renewals — those are the primary catalysts for a re-rate.
I'll revisit sizing and targets as the company provides funding details and capacity timelines. For now, the trade is a disciplined, risk-managed way to own one of the fastest-growing AI-cloud builders while protecting capital if the company's large build-out falters.